Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intravenous recombinant interferon-beta versus interferon-alpha-2b and ribavirin in combination for short-term treatment of chronic hepatitis C patients not responding to interferon-alpha. Multicenter Interferon Beta Italian Group Investigators.
Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Pellicelli A, Grisorio B, Barbarini G. Barbaro G, et al. Among authors: giancaspro g. Scand J Gastroenterol. 1999 Sep;34(9):928-33. doi: 10.1080/003655299750025426. Scand J Gastroenterol. 1999. PMID: 10522614 Clinical Trial.
Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study.
Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Francavilla R, Rizzo G, Barbarini G. Barbaro G, et al. Among authors: giancaspro g. Am J Gastroenterol. 1998 Dec;93(12):2445-51. doi: 10.1111/j.1572-0241.1998.00702.x. Am J Gastroenterol. 1998. PMID: 9860407 Clinical Trial.
Evaluation of long-term efficacy of interferon alpha-2b and ribavirin in combination in naive patients with chronic hepatitis C: an Italian multicenter experience. Ribavirin-Interferon in Chronic Hepatitis Italian Group Investigators.
Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Pellicelli A, Grisorio B, Barbarini G. Barbaro G, et al. Among authors: giancaspro g. J Hepatol. 2000 Sep;33(3):448-55. doi: 10.1016/s0168-8278(00)80281-0. J Hepatol. 2000. PMID: 11020001 Clinical Trial.
Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA).
Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Grisorio B, Pellicelli A, Barbarini G. Barbaro G, et al. Among authors: giancaspro g. Circulation. 1999 Aug 31;100(9):933-9. doi: 10.1161/01.cir.100.9.933. Circulation. 1999. PMID: 10468523
Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-alpha and nitric oxide synthase.
Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Grisorio B, Pellicelli AM, D'Amati G, Barbarini G; GISCA. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS. Barbaro G, et al. Among authors: giancaspro g. AIDS. 2000 May 5;14(7):827-38. doi: 10.1097/00002030-200005050-00009. AIDS. 2000. Retraction in: AIDS. 2004 May 21;18(8):1087. doi: 10.1097/00002030-200405210-00001 PMID: 10839591 Retracted.
68 results